Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19

Different dosage regimens of hydroxychloroquine (HCQ) have been used to manage COVID-19 (coronavirus disease 2019) patients, with no information on lung exposure in this population. The aim of our study was to evaluate HCQ concentrations in the lung epithelial lining fluid (ELF) in patients infected...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Antimicrob Agents
Glavni autori: Ruiz, S., Concordet, D., Lanot, T., Georges, B., Goudy, P., Baklouti, S., Mané, C., Losha, E., Vinour, H., Rousset, D., Lavit, M., Minville, V., Conil, J-M, Gandia, P.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7698654/
https://ncbi.nlm.nih.gov/pubmed/33259916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106247
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items